Discovery Spark is back, and Discovery Park are now accepting applications for the next cohort!
If you're pioneering in Biotech, MedTech, Diagnostics, Advanced Therapies, or beyond, this free and unique programme is tailor-made to help you overcome the hurdles of early-stage growth and scale your business with confidence.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…